Letters to the Editor

Single-cell analysis of the T-cell receptor repertoire in untreated myeloma patients suggests potential myeloma-reactive CD8+ T-cells are shared between blood and marrow

Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales
Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales
Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales
Sydney Local Health District Clinical Research Institute, Royal Prince Alfred Hospital, Camperdown, New South Wales
Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales
Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales
School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales
School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales
Institute for Clinical Pathology and Medical Research (ICPMR), New South Wales Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia; Center for Virus Research, Westmead Institute for Medical Research, Westmead, New South Wales
Orthopedics Department, Sydney Local Health District, Royal Prince Alfred Hospital, Camperdown, New South Wales
Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales
Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, NSW
Haematologica Early view Oct 3, 2024 https://doi.org/10.3324/haematol.2024.285952